Lumen Bioscience patents spirulina genetic engineering

Lumen Bioscience, a Seattle biotechnology company focused on orally delivered antibody therapeutics and other biologics, has announced that the U.S. Patent and Trademark Office has issued the company Patent No. 10,131,870, entitled “Targeted Mutagenesis in Spirulina”… [Read the full story]